It does not require to have a bottle to draw insulin, easy adjustment of dose, less wastage of expired insulin, it doesn't require refrigeration to store as compared to other insulin delivery methods.
According to Renub Research report, the Global Insulin Pen Market will increase year on year; and reach US$ 35 Billion by the end of the year 2025.There are three types of insulin pens available: Disposable, Reusable and Smart Insulin Pen.
The third type of insulin pen is smart with the use of advanced technologies such as Bluetooth or IoT; it can record the time and date of insulin at which dose was delivered, nowadays these smart insulin pens are also called as "Connected Insulin Pen"The Impact of COVID-19 on Insulin Pen MarketHealthcare industry is facing significant challenges due to the outbreak of Coronavirus.
Major healthcare companies are focusing on the vaccine of this deadly virus, and investment for the treatment of other diseases has been stopped.
According to Renub Research analysis, Disposable insulin pen has the most significant market share.By Company: This research report provides Overview, Recent Developments and Sales Analysis of B.Braun Melsungen AG, Eli Lilly and Company, Artsana S.p.A., BD (Becton Dickinson), Novo Nordisk A/S, Mumford Ltd.About Company:Renub Research is a Market Research and Consulting Company.
We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting.